FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Bayer news from FiercePharma

News

Bayer on the prowl for weaker prey

Bayer appears to be working under Warren Buffett's market-turmoil philosophy: Be fearful when others are greedy and... Read more...

Bayer - Top 13 Ad Budgets

Company: Bayer 2007 Ad Spending: $861 million2006 Ad Spending: $683.4 million Breakdown Magazines: $102.5 million Newspaper: $16.1 million Outdoor: $900,000 TV: $330.6 million Radio: $18... Read more...

Bayer CEO scoffs at takeover talk

Market watchers can wag their tongues all they like, says Bayer CEO Werner Wenning (photo). The company isn't... Read more...

Bayer up on Pfizer buyout talk

Market matchmakers won't leave Pfizer alone. Today, rumors are circulating that the drugmaker is... Read more...

Bid-happy analysts play matchup

Analysts just can't get their minds off which drugmakers might make a deal next. The most recent suspects are Bayer and Onyx, which are partnered on the Read more...

AZ raises forecast; Sanofi reports 'bloodbath'

More big earnings news today, with the undisputed winner being AstraZeneca, which raised its 2008 forecast and trounced analyst expectations for the quarter. Not so lucky: Sanofi-Aventis, whose... Read more...

Bayer eyes 20% annual growth in China

Like its Big Pharma brethren, Bayer is casting a gimlet eye on the drug market in China. The company says it's aiming for 20 percent-plus annual growth in China for each of the next five years. Most... Read more...

Barr, Bayer clinch generic Yasmin deal

Another generic deal that antitrust watchdogs love to hate: Barr Pharmaceuticals inked a deal to sell an "authorized generic" version of Bayer's birth control pill Yasmin by July 1, several years... Read more...

Bayer fined $16.2M in price-fixing probe

Bayer was fined $16.2 million for fixing the prices of aspirin and other over-the-counter meds in Germany; the government alleged that a local Bayer subsidiary made illegal rebate deals with more... Read more...

Swiss pricing pressure angers Vasella

Daniel Vasella (photo) is riled. The Novartis CEO says its hometown officials are putting too much pressure on drug... Read more...